Author

Anissa R. Ramos

Scripps Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Charles O. RockiD· 1 shared Chitra SubramanianiD· 1 shared Christopher J. OttiD· 1 shared Eric M. BilottaiD· 1 shared Joshua N. AsiabaniD· 1 shared Leopold Garnar-WortzeliD· 1 shared Michael A. ErbiD· 1 shared Timothy R. BishopiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Charles O. RockORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic adaptations underpin resistance to histone acetyltransferase inhibition

Timothy R. Bishop, Chitra Subramanian, Eric M. Bilotta, Leopold Garnar-Wortzel, Anissa R. Ramos, Yuxiang Zhang, Joshua N. Asiaban, Christopher J. Ott, Charles O. Rock, Michael A. Erb

This study identifies CoA metabolism dysregulation as a mechanism of resistance to HAT inhibitors in AML, revealing a potential class-wide vulnerability for anti-cancer therapies targeting HATs.

Nature Chemical Biology · May 1, 2023Peer-reviewedMolecular Biology